Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: Very High
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
48,438
Total Claims
$3.4M
Drug Cost
1,402
Beneficiaries
$2,458
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 9,082 Pulmonary Disease providers
-52%
Cost per patient vs peers
$2,458 vs $5,138 avg
-78%
Brand preference vs peers
13.6% vs 61.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.8%
Opioid Rate
393
Opioid Claims
$15K
Opioid Cost
12.5%
Long-Acting Rate
Brand vs Generic
Brand: 6,557 claims · $2.4M
Generic: 41,702 claims · $1.0M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,255 | $344K |
| Paliperidone Palmitate | 57 | $201K |
| Fluticasone/Umeclidin/Vilanter | 199 | $135K |
| Alpha-1-Proteinase Inhibitor | 12 | $133K |
| Dulaglutide | 122 | $115K |
| Linagliptin | 452 | $111K |
| Rivaroxaban | 357 | $97K |
| Valbenazine Tosylate | 16 | $91K |
| Rifaximin | 34 | $86K |
| Fluticasone/Vilanterol | 136 | $69K |
| Dextromethorphan Hbr/Quinidine | 86 | $61K |
| Eslicarbazepine Acetate | 105 | $60K |
| Empagliflozin | 171 | $49K |
| Risperidone Microspheres | 57 | $47K |
| Memantine Hcl | 754 | $44K |
Prescribing Profile
Patient Profile
77
Avg Age
64%
Female
2.61
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About